Table 2

Lack of overlap among BRAF, RAS, and RET/PTC mutations in papillary carcinomas

Mutation prevalenceBRAFRASRET/PTC
BRAF32.8%22/6700
RAS16.4%011/670
RET/PTC16.4%0011/67
Total65.6%